Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGDS | O60760 | 2/20 | 0.61 |
| ▸ | HPGD | P15428 | 2/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.59 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.59 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.59 |
| ▸ | ACKR3 | P25106 | 2/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.56 |
| ▸ | NAAA | Q02083 | 1/20 | 0.55 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | ATM | Q13315 | 2/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | NPY1R | P25929 | 1/20 | 0.52 |
| ▸ | NPY2R | P49146 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20170935 | 1.00 | HPGDS (0.61) | HPGDSHPGDCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL3436271 | 0.90 | HPGD (0.66) | HPGDSHPGDCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL12789158 | 0.84 | HPGD (0.69) | HPGDSHPGDCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL7364347 | 0.84 | HDAC1 (0.58) | HPGDSHPGDCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL27965799 | 0.82 | HDAC1 (0.65) | HPGDSHPGDCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL27965984 | 0.82 | RAB9A (0.66) | HPGDSHPGDCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL27965978 | 0.82 | RAB9A (0.61) | HPGDSHPGDCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL2101661 | 0.82 | HDAC3 (0.51) | HPGDSHPGDHDAC1HDAC6HDAC8 | |
| SCHEMBL27966332 | 0.82 | HPGD (0.66) | HPGDSHPGDCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL27966030 | 0.81 | HPGDS (0.49) | HPGDSHPGDCYP1A2CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7307093-B2 | Cancer, selectivity to prostate cancer cell lines, ovarian cancer cells | THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2007-12-11 | — | — | US | claimed |
| CN-1902184-A | Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof | UNIV TENNESSEE RES FOUNDATION (US) | 2007-01-24 | — | — | CN | claimed |
| EP-1692121-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, METHODS OF MAKING, AND USES THEREOF | University of Tennessee Research Foundation (US) | 2006-08-23 | — | — | EP | claimed |
| US-20060040998-A1 | Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof | THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2006-02-23 | — | — | US | claimed |
| WO-2005049591-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, METHODS OF MAKING, AND USES THEREOF | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2005-06-02 | — | — | WO | claimed |
| US-7662842-B2 | Thiazolidinone amides, thiazolidine carboxylic acid amides, and serine amides, including polyamine conjugates thereof, as selective anti-cancer agents | Ohio State Univesity Research Foundation (US) | 2010-02-16 | — | — | US | disclosed |
| US-20090143446-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, METHODS OF MAKING, AND USES THEREOF | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2009-06-04 | — | — | US | disclosed |
| US-20090143446-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, METHODS OF MAKING, AND USES THEREOF | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2009-06-04 | — | — | US | disclosed |
| WO-2008128179-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, AND SERINE AMIDES, INCLUDING POLYAMINE CONJUGATES THEREOF, AS SELECTIVE ANTI-CANCER AGENTS | THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2008-10-23 | — | — | WO | disclosed |
| US-20080255213-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, AND SERINE AMIDES, INCLUDING POLYAMINE CONJUGATES THEREOF, AS SELECTIVE ANTI-CANCER AGENTS | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2008-10-16 | — | — | US | disclosed |
| US-20080255213-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, AND SERINE AMIDES, INCLUDING POLYAMINE CONJUGATES THEREOF, AS SELECTIVE ANTI-CANCER AGENTS | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2008-10-16 | — | — | US | disclosed |
| EP-1926487-A2 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, AND SERINE AMIDES, INCLUDING POLYAMINE CONJUGATES THEREOF, AS SELECTIVE ANTI-CANCER AGENTS | University of Tennessee Research Foundation (US) | 2008-06-04 | — | — | EP | disclosed |
| US-20070155807-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, AND SERINE AMIDES, INCLUDING POLYAMINE CONJUGATES THEREOF, AS SELECTIVE ANTI-CANCER AGENTS | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2007-07-05 | — | — | US | disclosed |
| CN-1902184-A | Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof | UNIV TENNESSEE RES FOUNDATION (US) | 2007-01-24 | — | — | CN | disclosed |
| EP-1723127-A2 | ANALOGS EXHIBITING INHIBITION OF CELL PROLIFERATION, METHODS OF MAKING, AND USES THEREOF | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2006-11-22 | — | — | EP | disclosed |
| EP-1692121-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, METHODS OF MAKING, AND USES THEREOF | University of Tennessee Research Foundation (US) | 2006-08-23 | — | — | EP | disclosed |
| US-20060040998-A1 | Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof | THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2006-02-23 | — | — | US | disclosed |
| US-20060014740-A1 | Analogs exhibiting inhibition of cell proliferation, methods of making, and uses thereof | US GOVERNMENT - SECRETARY FOR THE ARMY | 2006-01-19 | — | — | US | disclosed |
| WO-2005086638-A2 | ANALOGS EXHIBITING INHIBITION OF CELL PROLIFERATION, METHODS OF MAKING, AND USES THEREOF | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2005-09-22 | — | — | WO | disclosed |
| WO-2005049591-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, METHODS OF MAKING, AND USES THEREOF | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2005-06-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090143446-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, METHODS OF MAKING, AND USES THEREOF | NAT1, AADAC, PPARG | HPGDS 510/4885HPGD 371/4885CYP1A2 362/4885 |
| US-20060014740-A1 | Analogs exhibiting inhibition of cell proliferation, methods of making, and uses thereof | MKI67, MCL1, API5 | HPGDS 58/4885HPGD 242/4885CYP1A2 2917/4885 |
| US-20060040998-A1 | Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof | NAT1, AADAC, PPARG | HPGDS 510/4885HPGD 371/4885CYP1A2 362/4885 |
| US-20080255213-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, AND SERINE AMIDES, INCLUDING POLYAMINE CONJUGATES THEREOF, AS SELECTIVE ANTI-CANCER AGENTS | SRM, SAT1, SMS | HPGDS 606/4885HPGD 1254/4885CYP1A2 3912/4885 |
| US-20070155807-A1 | THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, AND SERINE AMIDES, INCLUDING POLYAMINE CONJUGATES THEREOF, AS SELECTIVE ANTI-CANCER AGENTS | SRM, SAT1, SMS | HPGDS 540/4885HPGD 969/4885CYP1A2 3066/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.